AWH

Aspira Womans Health (AWH)

Aspira Womans Health Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AWH

<< 前へ 1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/05/12	05 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AWH	Aspira Womans Health Inc
2023/05/12	01 : 33	GlobeNewswire Inc.	Aspira Women’s Health Announces 1-for-15 Reverse Stock Split	NASDAQ:AWH	Aspira Womans Health Inc
2023/05/11	22 : 45	GlobeNewswire Inc.	New to The Street Announces the Televised Lineups for Shows 466, 467, and 468; Airings on Three Networks, Starting Thursday, May 11, 2023, at 10:30 PM PT	NASDAQ:AWH	Aspira Womans Health Inc
2023/05/11	21 : 00	GlobeNewswire Inc.	Aspira Women’s Health Signs an Exclusive Licensing Agreement with Dana Farber Cancer Institute for the Development of microRNA-based Ovarian Cancer Test	NASDAQ:AWH	Aspira Womans Health Inc
2023/05/11	05 : 38	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AWH	Aspira Womans Health Inc
2023/05/10	05 : 07	GlobeNewswire Inc.	Aspira Women’s Health Appoints Three New Members to its Board of Directors	NASDAQ:AWH	Aspira Womans Health Inc
2023/04/05	05 : 05	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:AWH	Aspira Womans Health Inc
2023/04/04	19 : 08	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:AWH	Aspira Womans Health Inc
2023/03/30	22 : 26	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AWH	Aspira Womans Health Inc
2023/03/30	21 : 03	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:AWH	Aspira Womans Health Inc
2023/03/29	22 : 29	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:AWH	Aspira Womans Health Inc
2023/03/23	05 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AWH	Aspira Womans Health Inc
2023/03/23	05 : 05	GlobeNewswire Inc.	Aspira Women’s Health Reports Fourth Quarter and Full Year 2022 Financial Results	NASDAQ:AWH	Aspira Womans Health Inc
2023/03/21	06 : 30	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:AWH	Aspira Womans Health Inc
2023/03/14	06 : 14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AWH	Aspira Womans Health Inc
2023/03/03	22 : 38	GlobeNewswire Inc.	Aspira Women’s Health to Announce Year End 2022 Financial Results and Host Conference Call on March 22, 2023	NASDAQ:AWH	Aspira Womans Health Inc
2023/03/03	22 : 00	GlobeNewswire Inc.	Aspira Women’s Health Announces National Payer Coverage for OvaWatch	NASDAQ:AWH	Aspira Womans Health Inc
2023/03/02	22 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AWH	Aspira Womans Health Inc
2023/02/16	07 : 29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AWH	Aspira Womans Health Inc
2023/02/11	08 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AWH	Aspira Womans Health Inc
2023/02/11	08 : 09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AWH	Aspira Womans Health Inc
2023/02/11	07 : 22	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:AWH	Aspira Womans Health Inc
2023/02/08	06 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AWH	Aspira Womans Health Inc
2023/01/11	06 : 48	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:AWH	Aspira Womans Health Inc
2023/01/10	22 : 18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AWH	Aspira Womans Health Inc
2023/01/10	06 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AWH	Aspira Womans Health Inc
2023/01/10	06 : 05	GlobeNewswire Inc.	Aspira Women’s Health Announces Preliminary Fourth Quarter 2022 Volume, Preliminary Results in Line with Cash Utilization Guidance, and Other Highlights	NASDAQ:AWH	Aspira Womans Health Inc
2023/01/06	22 : 00	GlobeNewswire Inc.	Aspira Women’s Health Announces Publication of Real-World Data Validating Use of OvaWatch for the Management of Adnexal Masses	NASDAQ:AWH	Aspira Womans Health Inc
2022/12/29	06 : 55	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AWH	Aspira Womans Health Inc
2022/12/29	06 : 40	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:AWH	Aspira Womans Health Inc